|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007193,
umls-concept:C0014653,
umls-concept:C0035647,
umls-concept:C0035820,
umls-concept:C0040300,
umls-concept:C0086418,
umls-concept:C0205349,
umls-concept:C0206528,
umls-concept:C0243077,
umls-concept:C0243125,
umls-concept:C0331858,
umls-concept:C0337112,
umls-concept:C0699900,
umls-concept:C1524075,
umls-concept:C1704640,
umls-concept:C1706515
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-8-24
|
|
pubmed:abstractText |
End-stage of human dilated cardiomyopathy (DCM) is characterized by myocyte loss and fibrosis, and associated with ventricular dilatation and reduced cardiac function. Matrix metalloproteinases (MMPs) and their natural tissue inhibitors (TIMPs) have been involved in the myocardial remodeling.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1388-9842
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
337-52
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:10937947-Adult,
pubmed-meshheading:10937947-Cardiomyopathy, Dilated,
pubmed-meshheading:10937947-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:10937947-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:10937947-Female,
pubmed-meshheading:10937947-Heart Ventricles,
pubmed-meshheading:10937947-Humans,
pubmed-meshheading:10937947-Immunohistochemistry,
pubmed-meshheading:10937947-Male,
pubmed-meshheading:10937947-Matrix Metalloproteinase 2,
pubmed-meshheading:10937947-Matrix Metalloproteinase 9,
pubmed-meshheading:10937947-Middle Aged,
pubmed-meshheading:10937947-Myocardium,
pubmed-meshheading:10937947-Myosin Heavy Chains,
pubmed-meshheading:10937947-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10937947-Tissue Inhibitor of Metalloproteinases
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.
|
|
pubmed:affiliation |
Unité INSERM U492, Faculté de Médecine, Créteil, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
